EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Supplements A–Z Other Sources: 6

Bromelain

Also called: pineapple enzyme

A group of protein-digesting enzymes (cysteine proteinases) from the stem and fruit of the pineapple plant (Ananas comosus). It is promoted as a dietary supplement and is also used topically in a prescription drug for removing dead tissue from severe burns.

Category
Other
Forms
Bromelain enzyme concentrate from pineapple stem and fruit
Strongest evidence
B Some positive trials
Reviewed
2026-10-30

Class 1 Well studied in people. A 2019 meta-analysis pooled six RCTs comparing oral bromelain with placebo or no treatment after third molar (wisdom tooth) surgery. [4]

Fact-checked 2026-10-30 · How this guide is made

Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.

Evidence

What research has studied

Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.

5 topics studied5 body areas · strongest grade B

A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials

From the table below Each topic in the table is placed on the part of the body it names, colored by its strongest grade. Tap an area, or open a line in the list, to see its topics. The map shows what was studied, not what Bromelain does: a C or X area is not evidence of benefit. All 1,071 findings on one body map.
Topics studied for Bromelain, evidence grade and finding
Topic studiedGradeWhat the evidence shows
Pain and recovery after wisdom tooth (third molar) surgeryBA 2019 meta-analysis (6 RCTs) found less pain in the first 24 hours and at 7 days and better quality-of-life scores, but no evidence that bromelain reduced trismus or facial swelling. [4]
Pain (oral bromelain across conditions)CA 2023 meta-analysis found pain reduction from oral bromelain slightly but significantly better than controls (mean difference -0.27; 9 studies); bromelain was not effective for cardiovascular diseases. [5]
SinusitisCNCCIH: a small number of studies have been done; there is not enough high-quality research to say whether oral bromelain should be recommended for sinusitis. [1]
Burn and wound debridement (topical prescription use)BTopical bromelain shortened the time to complete debridement (mean difference -6.89 days; 4 studies) in a 2023 meta-analysis. This is topical medical use, not oral supplement use. [5]
Fibrinogen and cardiovascular risk factorsCMSK: bromelain does not appear to reduce fibrinogen or influence other cardiovascular disease risk factors. [2]

Main constituents: Bromelain, a sulfhydryl proteolytic enzyme (cysteine proteinase) [2]

Amounts

Amounts studied and limits

Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.

  • LiverTox: the dose varies by source and medical use between 200 and 2000 mg daily. [3]

No official upper intake level has been set.

Safety

Safety and side effects

  • Liver (NIH LiverTox)
    Score E
    A: well known causeE: unlikely cause

    NIH LiverTox, Bromelain (last update February 10, 2024): likelihood score E, unlikely cause of clinically apparent liver injury.

    Details and sources
  • Pregnancy and breastfeeding
    NCCIH: little is known about whether it is safe to use bromelain during pregnancy or while breastfeeding.

    1 statement in the profile.

    Details and sources
  • Interactions with medicines
    3 listed

    Antibiotics (tetracyclines); Anticoagulants; CYP2C9 substrate drugs

    Details and sources
  • Cancer evaluations (IARC, NTP)
    None found

    No IARC or NTP evaluation was found in the lists checked.

    Details and sources
  • FDA new dietary ingredient notifications
    1 on FDA's list

    FDA does not approve dietary supplements. Each entry is one party's filing.

    Details and sources
  • Dose in official monographs
    None found

    No published information found in the sources checked.

    Details and sources
  • NIH LiverTox (last update February 10, 2024): likelihood score E, unlikely cause of clinically apparent liver injury; no reports of liver injury, jaundice or hepatotoxicity with oral or topical use. [3]
  • LiverTox: side effects are uncommon and typically mild abdominal discomfort and nausea; hypersensitivity reactions such as urticaria and rash are usually mild, and rare instances of anaphylaxis have been described. [3]
  • NCCIH: taken orally, bromelain seems to be well tolerated; the most commonly reported side effects are stomach upset and diarrhea. Little is known about safety during pregnancy or breastfeeding. [1]
Interactions

Interactions

Bromelain
From the table below 3 interactions the sources name. Tap one to read what happens. A line means a documented or possible interaction, not its size.
Known interactions of Bromelain
WithWhat happens
Antibiotics (tetracyclines)MSK: bromelain may increase blood and urine levels of these drugs by increasing their absorption in the intestine. [2]
AnticoagulantsMSK: preclinical studies suggest bromelain may increase bleeding risk due to its antithrombotic effects; clinical relevance has yet to be determined. [2]
CYP2C9 substrate drugsMSK: in vitro, bromelain inhibits CYP2C9 activity and may affect metabolism of substrate drugs; clinical relevance has yet to be determined. [2]

Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.

Regulation

Regulatory status

  • US: NCCIH states bromelain is promoted as a dietary supplement. Separately, a prescription drug product containing bromelain for topical debridement of severe burns in adults received FDA approval in 2022 and is also approved in the European Union; that is a drug, not a dietary supplement. [1]
  • US: under DSHEA, FDA does not have the authority to approve dietary supplements before they are marketed; firms are responsible for ensuring their products are not adulterated or misbranded. [6]
Profile

Safety, quality and supply profile

Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-30). If our sources do not answer a question, we say so.

Compounds responsible

Compounds the sources name as the main or characteristic actives.

  • Bromelain (proteolytic enzymes) Enzyme (cysteine proteinase) [P6]

US status

What FDA's published records show. FDA does not approve dietary supplements.

  • FDA's published NDI notification list has 1 entry naming bromelain as a single ingredient (NDI 933 submitted 2016-07-04, a protease enzyme derived from Ananas comosus); one multi-ingredient entry (NDI 504, submitted 2007-12-03) also includes bromelain. Each notification covers one firm's specific ingredient and conditions of use; the list does not state FDA's response. [P1]

Cancer evaluations (IARC and NTP)

Evaluations name the exact material tested, which may differ from a supplement.

  • No IARC or NTP carcinogenicity evaluation of bromelain was found (IARC Monographs list of classifications and NTP technical reports checked 2026-10-30). [P2]
  • The NTP Technical Reports index (TR-001 to TR-606) lists no 2-year study of bromelain (checked 2026-10-30). [P3]

Liver (NIH LiverTox)

  • NIH LiverTox, Bromelain (last update February 10, 2024): likelihood score E, unlikely cause of clinically apparent liver injury. [P5]

Interactions with medicines

  • Antibiotics (tetracyclines): MSK: bromelain may increase blood and urine levels of these drugs by increasing their absorption in the intestine. [P6]
  • Anticoagulants: MSK: preclinical studies suggest bromelain may increase bleeding risk due to its antithrombotic effects; clinical relevance has yet to be determined. [P6]
  • CYP2C9 substrate drugs: MSK: in vitro, bromelain inhibits CYP2C9 activity and may affect metabolism of substrate drugs; clinical relevance has yet to be determined. [P6]

Alcohol

  • No published information found in the sources checked.

Interactions with other herbs and supplements

  • No published information found in the sources checked.

Adulteration and substitution

  • No published information found in the sources checked.

What a certificate of analysis should cover

Tests a quality specification for this material would include, with the reason for each.

  • Identity: at least one appropriate test or examination to verify the identity of each component that is a dietary ingredient (21 CFR 111.75(a)(1)(i)) — General Part 111 requirement for every dietary ingredient; FDA may exempt a firm only by granting a petition under 111.75(a)(1)(ii). [P4]

Supply and conservation

  • GBIF species API returns IUCN Red List category Not Evaluated (NE) for Ananas comosus, retrieved 2026-10-30. [P9]

Absorption in people

  • Leelakanok et al. (2023 systematic review): bromelain was present in serum with retained proteolytic activity after oral absorption. [P8]

Formulations studied to change absorption

Human data only.

  • No published information found in the sources checked.

Dose in official monographs

As the monograph states it, for its jurisdiction; not personal advice.

  • No published information found in the sources checked.

Pregnancy and breastfeeding

  • NCCIH: little is known about whether it is safe to use bromelain during pregnancy or while breastfeeding. [P7]

Sources for this profile

  1. FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
  2. IARC Monographs. List of Classifications (last update 2026-07-23; checked 2026-10-30), 2026-07-23. monographs.iarc.who.int
  3. National Toxicology Program. Technical Reports (TR series index, TR-001 to TR-606; checked 2026-10-30), 2026-10-30. ntp.niehs.nih.gov
  4. eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (current text, retrieved 2026-10-30), 2026-10-30. ecfr.gov
  5. NIH LiverTox. Bromelain (Last Update: February 10, 2024), 2024-02-10. ncbi.nlm.nih.gov
  6. Memorial Sloan Kettering Cancer Center. About Herbs: Bromelain (last updated Tuesday, December 19, 2023), 2023-12-19. mskcc.org
  7. NCCIH. Bromelain (Last Updated: November 2024), 2024-11. nccih.nih.gov
  8. Leelakanok N, et al. Efficacy and safety of bromelain: a systematic review and meta-analysis. Nutr Health 2023;29(3):479-503 (PMID 37157782), 2023-09. pubmed.ncbi.nlm.nih.gov
  9. GBIF species API: IUCN Red List category for Ananas comosus (L.) Merr. (usageKey 5288819), 2026-10-30. api.gbif.org
Sources

Sources

  1. NCCIH. Bromelain (Last Updated: November 2024), 2024-11. nccih.nih.gov
  2. Memorial Sloan Kettering Cancer Center. About Herbs: Bromelain (last updated Tuesday, December 19, 2023), 2023-12-19. mskcc.org
  3. NIH LiverTox. Bromelain (Last Update: February 10, 2024), 2024-02-10. ncbi.nlm.nih.gov
  4. Mendes ML, et al. Efficacy of proteolytic enzyme bromelain on health outcomes after third molar surgery. Systematic review and meta-analysis of randomized clinical trials. Med Oral Patol Oral Cir Bucal 2019;24(1):e61-e69 (PMID 30573710), 2019-01-01. pubmed.ncbi.nlm.nih.gov
  5. Leelakanok N, et al. Efficacy and safety of bromelain: a systematic review and meta-analysis. Nutr Health 2023;29(3):479-503 (PMID 37157782), 2023-09. pubmed.ncbi.nlm.nih.gov
  6. U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (Content current as of 08/27/2026), 2026-08-27. fda.gov
A
Consistent results from several randomized trials or a systematic review of them
B
Some positive randomized trials, but small, short, few or inconsistent
C
Limited human evidence: single small trials, observational data or mixed results
D
Laboratory or animal evidence only; not shown in people
X
Well-designed human trials found no meaningful effect

More in this category: Alpha-lipoic acid · Bee pollen · Beetroot juice (dietary nitrate) · Berberine · Beta-glucan (oat and barley) · Betaine (trimethylglycine) · Caffeine · Choline · All entries A–Z · How to judge a supplement

Health information notice

These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to check what you take?

Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.